Search

everythinglearnresearchcommunity

for

Search:↓

Certain IL-18 gene variations may increase the risk of alopecia areata.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

MG53 helps reduce skin damage caused by nitrogen mustard.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Blocking interferon-gamma might help treat various autoimmune diseases.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Ostrich antibodies helped regrow hair in men with hair loss, but the application needs to be easier.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Gray hair can potentially be reversed, leading to new treatments.

Antibody treatments show promise for hair loss but need more research.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Finasteride helps prevent kidney stones, but side effects need more research.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.